Detalles de la búsqueda
1.
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
J Infect Dis
; 215(1): 24-33, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27694633
2.
A multi-criteria decision making approach to identify a vaccine formulation.
J Biopharm Stat
; 26(2): 352-64, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-25616785
3.
Influenza vaccine efficacy trials: a simulation approach to understand failures from the past.
Pharm Stat
; 14(4): 294-301, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924929
4.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
J Infect Dis
; 208(4): 544-53, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23847058
5.
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.
BMC Infect Dis
; 13: 224, 2013 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23688546
6.
Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.
BMC Infect Dis
; 13: 348, 2013 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23890405
7.
Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.
Hum Vaccin Immunother
; 16(6): 1327-1337, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31951765
8.
Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept.
J Chromatogr A
; 1158(1-2): 126-37, 2007 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-17420025
9.
Partial within-animal calibration: a new calibration approach in lead optimisation high-throughput bioanalysis.
J Chromatogr B Analyt Technol Biomed Life Sci
; 854(1-2): 183-91, 2007 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17507297
10.
Exploring drug solubility in fasted human intestinal fluid aspirates: Impact of inter-individual variability, sampling site and dilution.
Int J Pharm
; 528(1-2): 471-484, 2017 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28591618
11.
Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.
Clin Vaccine Immunol
; 24(6)2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28446441
12.
Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.
Hum Vaccin Immunother
; 12(9): 2289-98, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27105343
13.
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.
Hum Vaccin Immunother
; 12(12): 3043-3055, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690762
14.
What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?
J Clin Psychiatry
; 66(7): 859-63, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16013901
15.
Influence of the nature of the electrolyte on the chiral separation of basic compounds in nonaqueous capillary electrophoresis using heptakis(2,3-di-O-methyl-6-O-sulfo)-beta-cyclodextrin.
J Chromatogr A
; 1068(1): 143-50, 2005 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-15844552
16.
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease.
Open Forum Infect Dis
; 2(2): ofv067, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26180823
17.
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
Vaccine
; 32(13): 1480-7, 2014 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24486352
18.
Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.
Hum Vaccin Immunother
; 10(10): 2942-57, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483467
19.
Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.
Expert Rev Clin Pharmacol
; 6(4): 403-11, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23927668
20.
Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.
Clin Vaccine Immunol
; 18(5): 835-43, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450978